Doha Debates Questions Whether Modern Architecture Contributes to Cultural Decline
Episode two of flagship debate show asks: Have we lost touch with beauty in the world we have built?
This week, Qatar Foundation’s Doha Debates examines how architecture reflects and shapes cultural values on their flagship show, Doha Debates. The second episode of the new season asks: Has modern architecture redefined beauty and tradition, or contributed to its decline?
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029822479/en/

Doha Debates brought together a distinguished group of architects, thinkers, and creatives to question whether modern architecture contributes to cultural decline. From left: Sundus Saeed, Ameer Sadi, Sara Akbar, Carl Jambo, Huda Muazzam Iqbal, Tariq Khayyat, Bidisha Sinha, Dareen Abughaida, Carl W. Korsnes, Marwa Al-Sabouni, Leen Nedal Yamin, Wahed Shaik, Lina Ayman Darwish, Mudassar Raza Shakir, and John Carlos Burog. (Photo: AETOSWire)
Moderated by Dareen Abughaida, the debate brings students from across Qatar with experts from around the world: Marwa Al-Sabouni, Syrian architect and author of The Battle for Home; Tariq Khayyat, founder of T.K. Architects and former director at Zaha Hadid Architects; Carl Korsnes, philosopher and editor-in-chief of Sivilisasjonen magazine; and Bidisha Sinha, associate director at Zaha Hadid Architects.
Korsnes and al-Sabouni argue that the 20th-century modernist paradigm stripped architecture of its soul. Abstraction and alienation replaced ornamentation, harmony, and human scale. Al-Sabouni draws from her experience rebuilding Homs in post-war Syria. Reflecting on how architecture shapes social cohesion, she warns, "The architectural idiom that we have adopted has embodied a cultural decline and an intellectual decline that has created the emptiness we see today."
In contrast, Sinha defends modern architecture as an evolving art form that redefines beauty for a new era. “Modernist architecture is more steered towards ideology rather than seeking beauty," she says.
Positioned between these poles, Khayyat calls for reconciliation between tradition and innovation. "I think we have lost touch with beauty,” he says. “We have lost touch with ourselves and how architecture plays an important role in enhancing our life experience."
As the debate unfolds, the experts and students wrestle with tensions between heritage and progress; local identity and global design; and timeless beauty versus evolving aesthetics. The conversation often returns to one shared conviction: Architecture is never neutral. It shapes how we live, the ideals we hold and how we connect to one another.
“Beauty is never just about what we see, it’s about what we value,” says Amjad Atallah, managing director of Doha Debates. “In this debate, young voices reminded us that architecture can distance us from our humanity or bring us closer to it. Their courage to question and reimagine what beauty means in the modern world shows exactly why these intergenerational dialogues matter.”
Filmed in Doha in the flagship program’s signature Majlis-style format, the episode embodies Doha Debates’ commitment to open, truth-seeking dialogue and fostering empathy and understanding across cultures and ideologies.
Watch the full episode on DohaDebates.com and the Doha Debates YouTube channel.
Doha Debates
Website: DohaDebates.com
X/Twitter: @DohaDebates
Instagram: @DohaDebates
YouTube: YouTube.com/DohaDebates
TikTok: @DohaDebates
About Doha Debates
Doha Debates engages a vanguard of intellectually curious truth-seekers to constructively debate differences in order to build a better future. We emphasize unity over division, encouraging conversations that bring us together rather than drive us apart.
Learn more at DohaDebates.com.
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20251029822479/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bending Spoons to acquire AOL following $2.8B debt financing29.10.2025 16:30:00 CET | Press release
Acquisition positions historic brand for its next phase of growth Technology company Bending Spoons today announced that it has entered into a definitive agreement to acquire AOL, the web portal and email provider, from Yahoo. The acquisition is expected to close by the end of the year, subject to customary closing conditions and regulatory approvals. “AOL is an iconic, beloved business that’s in good health, has stood the test of time, and we believe has unexpressed potential,” said Bending Spoons CEO and co-founder, Luca Ferrari. “By our estimation, AOL is one of the top ten most-used email providers in the world, with a highly retained customer base counting around 8 million daily and 30 million monthly active users. We intend to invest significantly to help the product and the business flourish. Bending Spoons has never sold an acquired business—we’re confident we’re the right long-term steward for AOL, and look forward to serving its large, loyal customer base for many years to co
SK pharmteco and LOTTE BIOLOGICS Sign Strategic Partnership to Strengthen Global ADC CDMO Capabilities29.10.2025 15:35:00 CET | Press release
Two global CDMO leaders have joined forces to strengthen their presence in the rapidly growing antibody-drug conjugate (ADC) market.The collaboration will deliver integrated, one-stop CDMO services spanning antibody drug substance, linker–payload production, and bioconjugation, supported by joint marketing based on deep ADC expertise. SK pharmteco and LOTTE BIOLOGICS have announced that they have signed a Letter of Intent (LOI) for a strategic collaboration to strengthen their competitiveness in the global antibody-drug conjugate (ADC) market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029483889/en/ Leaders from SK pharmteco and LOTTE BIOLOGICS at the LOTTE BIOLOGICS booth at CPHI Frankfurt, Germany, following the signing of the strategic collaboration Letter of Intent on October 29, 2025. From left to right: Joon Chang, CBO, LOTTE BIOLOGICS; Jiwon Chun, CGO, LOTTE BIOLOGICS; Kern Chang, CTO, LOTTE BIOLOGICS; Yooyeol
Phenom Named Strategic Leader in 2025 Fosway 9-Grid™ for Talent & People Success for Second Consecutive Year29.10.2025 14:30:00 CET | Press release
Positioning Recognises Phenom Applied AI Phenom, an applied AI company that helps organizations hire faster, develop better and retain longer, has been named a Strategic Leader in the 2025 Fosway 9-Grid™ for Talent and People Success for the second consecutive year, changing their position by demonstrating increased performance for enterprises while lowering the total cost of ownership. The placement is a testament to the value delivered by its AI, automation and experience approach. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029195746/en/ Phenom has been named a Strategic Leader in the 2025 Fosway 9-Grid™ for Talent and People Success for the second consecutive year, changing their position by demonstrating increased performance for enterprises while lowering the total cost of ownership. The placement is a testament to the value delivered by its AI, automation and experience approach. Fosway Group identifies Strategi
Ferring Pharmaceuticals to Explore Strategic Options for Rebyota®29.10.2025 14:00:00 CET | Press release
As part of our ongoing transformation to sharpen our focus, we have decided to explore strategic options for Rebyota® (faecal microbiota, live – jslm). To date, more than five thousand patients suffering from recurrent Clostridioides difficile infection (rCDI) have found new hope when treated with Rebyota®. Without commercial critical mass in this therapy area at Ferring, we believe that this first-in-class, innovative product could benefit many more patients with a new approach to its continued commercialisation. As a result, Ferring will reduce commercial efforts in the United States while ensuring uninterrupted access for patients. Approved by the U.S. Food and Drug Administration (FDA) in 2022, Rebyota® was the first FDA-approved faecal microbiota transplant, indicated for the prevention of rCDI in adults following antibiotic treatment for recurrent CDI. This milestone marked a significant advancement in understanding the role of the human microbiome in health and disease. Ferring
GigaDevice GD32F5xx and GD32G5xx Software Test Libraries (STL) Receive TÜV Rheinland IEC 61508 Functional Safety Certification29.10.2025 14:00:00 CET | Press release
GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, announced that its GD32F5xx and GD32G5xx Software Test Libraries have received IEC 61508 SC3 (SIL 2/SIL 3) functional safety certification from TÜV Rheinland. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029124621/en/ Certificate This milestone expands GigaDevice’s functional safety portfolio, which already includes the GD32H7 and GD32F30x STLs, and now covers a broad range of MCUs with Arm® Cortex®-M7, Cortex®-M4, and Cortex®-M33 cores. Building on this foundation, GigaDevice will continue to deliver high-performance and safety-focused hardware and software solutions for key applications such as industrial control, energy and power, and humanoid robotics. With the growing emphasis on safety across industries like industrial automation, functional safety has become a critical considerat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom